European Union - English - EMA (European Medicines Agency)

pinnacle biologics b.v.  - porfimer sodium - barrett esophagus - antineoplastic agents - photodynamic therapy (pdt) with photobarr is indicated for: ablation of high-grade dysplasia (hgd) in patients with barrett's oesophagus (bo)

Australia - English - Department of Health (Therapeutic Goods Administration)

pinnacle natural products pty ltd - arctium lappa,artemisia absinthium,azadirachta indica,capsicum annuum,equisetum arvense,filipendula ulmaria,foeniculum vulgare,fucus vesiculosus,medicago sativa,rosa canina,senna alexandrina,syzygium aromaticum,taraxacum officinale,trigonella -

Australia - English - Department of Health (Therapeutic Goods Administration)

pinnacle natural products pty ltd - arctium lappa,capsicum annuum,equisetum arvense,filipendula ulmaria,foeniculum vulgare,fucus vesiculosus,juniperus communis,potassium iodide,rosa canina,salix alba,syzygium aromaticum,taraxacum officinale,trigonella foenum-graecum,valeriana -

Australia - English - Department of Health (Therapeutic Goods Administration)

pinnacle natural products pty ltd - ginkgo biloba -

United States - English - NLM (National Library of Medicine)

pinnacle biologics, inc. - porfimer sodium (unii: y3834sik5f) (porfimer - unii:m15h03k69b) - porfimer sodium 75 mg in 31.8 ml - photofrin ® is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their healthcare provider, cannot be satisfactorily treated with nd:yag laser therapy. photofrin is indicated for the treatment of microinvasive endobronchial non-small-cell lung cancer (nsclc) in patients for whom surgery and radiotherapy are not indicated. photofrin is indicated for the reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nsclc. photofrin is indicated for the ablation of high-grade dysplasia in barrett’s esophagus patients who do not undergo esophagectomy. - photofrin is contraindicated in patients with porphyria. - photodynamic therapy (pdt) is contraindicated in patients with an existing tracheoesophageal or bronchoesophageal fistula. - pdt is contraindicated in patients with tumors eroding into a major blood vessel. - pdt is

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sopura australia pty. ltd. - hydrogen peroxide; peracetic acid - liquid concentrate - hydrogen peroxide ungrouped active 110.0 g/l; peracetic acid acid-general active 160.0 g/l - microbiocide

New Zealand - English - Ministry for Primary Industries

arxada nz limited - fluazinam - fluazinam 500 g/litre - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 43167 - acetabular shell - the pinnacle acetabular shells with gription are titanium shells coated in gription (titanium sintered particles on a titanium sintered beads substrate) to enable cementless, biological fixation into the prepared acetabulum. additionally, the pinnacle acetabular shells with gription are available with of a range of holes to allow screws. an appropriate liner is then placed into the implanted shell. the pinnacle acetabular shell with gription is the acetabular shell component used during primary or revision total hip arthoplasty and is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. total hip replacement is indicated in the following conditions: 1. a severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia. 2. avascular necrosis of the femoral head. 3. acute traumatic fracture of the femoral head or neck. 4. failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement. 5. certain cases of ankylosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 43168 - non-constrained polyethylene acetabular liner - the pinnacle marathon acetabular liner is constructed from cross-linked uhmwpe and has an inner diameter corresponding to the outer diameter of the femoral head with which it articulates. the outer diameter of the liner corresponds to the inner diameter of the acetabular shell which it snap-locks into. as part of a total hip arthroplasty, the pinnacle marathon acetabular liner is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 43168 - non-constrained polyethylene acetabular liner - the pinnacle altrx acetabular liner is made from cross-linked polyethylene and fixes into an acetabular shell and articulates with a femoral head. the liner variants each have specific benefit impacting joint biomechanics and range of motion. the neutral liner provides 180 degrees of head coverage. the +4 neutral has 4mm offset for soft tissue tensioning. the +4 10deg liner is optimised for range of motion. the lipped liner has 4 mm build-up for added stability. pinnacle altrx acetabular liners are one component of total hip arthroplasty which is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. total hip replacement is indicated in the following conditions: 1. a severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia. 2. avascular necrosis of the femoral head. 3. acute traumatic fracture of the femoral head or neck. 4. failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement. 5. certain cases of ankylosis.